INTRODUCTION
============

Prions are infectious agents arising from misfolded proteins. They cause transmissible spongiform encephalopathies (TSEs) typified by Creutzfeldt--Jakob disease in humans and bovine spongiform encephalopathy in cattle. Conversion of the normal prion protein (PrP) into its infectious PrP^Sc^ confirmation underlies the pathogenesis of TSEs ([@B11]). This protein-only mechanism of infectivity can also explain the unusual genetic behavior of several prions found in the yeast *Saccharomyces cerevisiae* ([@B61]; [@B2]). \[*PIN*^+^\] and \[*PSI*^+^\] are the best-studied yeast prions and are formed from the Rnq1 and Sup35 proteins, respectively ([@B61]; [@B14]). \[*PSI*^+^\] is the altered conformation of the Sup35 protein, which normally functions as a translation termination factor during protein synthesis. The de novo formation of \[*PSI*^+^\] is enhanced by the presence of the \[*PIN*^+^\] prion ([@B15], [@B13]; [@B44]), which is the altered form of the Rnq1 protein, whose native protein function is unknown ([@B54]).

Yeast Sup35 normally functions in translation termination in its soluble form but is sequestered away from this function in its amyloid or aggregated form ([@B61]). Recently, aggregated Sup35 has been shown to retain its translation termination function, and alterations in amyloid heterogeneity have been shown to underlie changes in Sup35 protein--only phenotypes ([@B47]). The amyloid state is a highly structured, insoluble fibrillar deposit, consisting of many repeats of the same protein. This type of aggregation is central to the pathology of many neurodegenerative diseases, including Alzheimer's, Parkinson's, Huntington's, and prion diseases. Although the exact point at which these disease-related proteins are toxic is debatable, it is well accepted that the process of amyloid formation is generally detrimental to human health. Fungal and mammalian prions form de novo, but the mechanism is poorly understood in molecular terms. An initial alternative conformational state might be instigated by spontaneous misfolding event(s) that might be triggered by mutation, mistranslation, environmental stresses, and/or disruption of the chaperone network ([@B12]). Hence any defense systems that can eliminate these initially misfolded species might prevent conversion to the amyloid or disease-causing form of the protein.

Studies in yeast cells have identified intricate protein quality control systems in which insoluble proteins are partitioned into defined sites in the cell; amyloid and amorphous aggregates are believed to be processed separately ([@B53]). The ubiquitin proteasome system (UPS) is the main proteolytic system that subsequently degrades misfolded and damaged proteins or proteins that are no longer required in cells. Proteins destined for degradation by the proteasome are tagged with ubiquitin, and previous studies showed that alterations in the ubiquitin system affect prion formation ([@B4]). In addition, a number of genes that affect the UPS have been identified in an unbiased genome-wide screen for factors that modify the frequency of \[*PSI*^+^\] induction ([@B56]). This suggests that the UPS normally functions to prevent conversion of misfolded Sup35 into its transmissible amyloid form. However, ubiquitinated Sup35 has not been directly detected in yeast, and it is unclear whether the proteasome plays a direct role in suppressing \[*PSI*^+^\] prion formation ([@B4]).

Autophagy is the cellular proteolytic system that degrades organelles and clears protein aggregates via vacuolar/lysosomal degradation ([@B45]). During autophagy, an elongated isolation membrane sequesters cell material for degradation, forming a double-membrane-bound vesicle called the autophagosome. Fusion of the autophagosome with vacuoles/lysosomes introduces acidic hydrolases, which degrade the contained proteins and organelles. The progress of the autophagy pathway is regulated by the products of autophagy-related genes (*ATG genes*). Approximately 35 *ATG* genes have been identified in yeast, and several mammalian homologues have been functionally characterized. A number of possible links between autophagy and protein aggregation diseases have been described. For example, a link between autophagy and prion disease was first suggested by the observance of autophagic vacuoles in neurons from a scrapie hamster model ([@B8]). Suppression of basal autophagy in mice causes neurodegenerative diseases, suggesting that autophagy plays a role in the clearance of misfolded proteins ([@B24]; [@B34]), and amyloidogenic aggregates such as those formed by α-synuclein and huntingtin have been identified as substrates of autophagy ([@B60]; [@B49]; [@B29]). In addition, a correlation has been observed between pharmacological interventions that induce autophagy and enhanced cellular degradation of prions in prion-infected neuronal cell models ([@B25]). All of this suggests that auto­phagy plays a protective role against prion toxicity. However, the molecular details of how autophagy might promote prion clearance/degradation are unclear, and it is unknown whether a defective autophagy pathway might promote increased prion formation/accumulation.

In the present study, we analyze the role of autophagy in protecting against de novo \[*PSI*^+^\] prion formation in yeast. We show that the frequency of \[*PSI*^+^\] and \[*PIN*^+^\] prion formation is elevated in mutants deficient in autophagy. Conversely, induction of autophagy acts to protect against de novo prion formation. We show that oxidatively damaged Sup35 accumulates in autophagy mutants and suggest that autophagy normally functions to remove such oxidatively damaged Sup35, preventing spontaneous prion formation. In agreement with this idea, we show that growth under anaerobic conditions suppresses the de novo formation of \[*PSI*^+^\] in an auto­phagy mutant.

RESULTS
=======

\[*PSI*^+^\] prions are formed in autophagy mutants
---------------------------------------------------

A representative range of autophagy mutants was constructed to determine whether Sup35 aggregation is elevated in the absence of autophagy. Deletion mutants were made in a \[*PIN*^+^\]\[*psi*^−^\] version of yeast strain 74D-694, which is commonly used for prion studies ([@B10]). Mutants were constructed in a \[*PIN*^+^\]\[*psi*^−^\] strain background with defects in the core autophagy machinery, including the Atg1 kinase complex (*atg1*), the PI3K complex (*atg14*), the Atg9 cycling complex (*atg9*), the Atg8 ubiquitin-like conjugation system (*atg8, atg4*), and the Atg12 ubiquitin-like conjugation system (*atg12, atg7*). Mutants were also constructed lacking a vacuolar lipase (*atg15*), a receptor protein for the cytoplasm-to-vacuole targeting (Cvt) pathway (*atg19*), an adapter protein required for cargo loading in pexophagy (*atg11*), and a mitochondrial cargo receptor required in mitophagy (*atg32*).

Sup35 aggregate formation was visualized using a *SUP35NM--green fluorescent protein* (GFP) fusion construct under the control of the copper-regulatable *CUP1* promoter ([@B46]). After short-term induction of this construct, diffuse cytoplasmic fluorescence is observed in \[*psi*^−^\] cells, whereas coalescence of newly made Sup35NM-GFP with preexisting Sup35 aggregates in \[*PSI*^+^\] cells allows the detection of \[*PSI*^+^\] foci. \[*PIN*^+^\]\[*psi*^−^\] strains were grown for 16 h and *SUP35NM-GFP* induced with copper for 1 h to visualize Sup35 aggregation. As expected, diffuse cytoplasmic fluorescence was observed in the control \[*psi*^−^\] strain ([Figure 1A](#F1){ref-type="fig"}). Similar diffuse cytoplasmic Sup35 fluorescence was detected in the *atg11* and *atg32* mutants. In contrast, many large Sup35 puncta were detected in all of the remaining *atg* mutants ([Figure 1A](#F1){ref-type="fig"}). Quantification of aggregate formation revealed that ∼2--5% of mutant cells examined contained visible fluorescent foci after 16 h of growth ([Figure 1B](#F1){ref-type="fig"}).

![\[*PSI*^+^\] prions are formed in autophagy mutants. (A) Representative fluorescence micrographs for the wild-type and indicated autophagy mutant strains containing the Sup35NM-GFP plasmid. The *Sup35NM-GFP* plasmid was induced for 1 h using copper before visualizing aggregate formation after 16 h of growth. (B) The aggregation frequency was calculated in the indicated autophagy mutants as a percentage of the number of cells containing fluorescent foci out of ∼300 cells counted. (C) Representative fluorescence micrographs for strains cured with GdnHCl.](4541fig1){#F1}

One well-defined genetic criterion for a yeast prion is its reversible curability ([@B61]). This is commonly tested using guanidine hydrochloride (GdnHCl), which blocks the propagation of yeast prions by inhibiting the key ATPase activity of Hsp104, a molecular chaperone that is absolutely required for yeast prion propagation ([@B20]; [@B32]). Curing autophagy mutants with GdnHCl resulted in diffuse cytoplasmic Sup35-GFP fluorescence, with no detectable foci, indicating that these puncta may represent \[*PSI^+^*\] prion formation rather than amorphous Sup35 protein aggregates ([Figure 1C](#F1){ref-type="fig"})

Increased frequency of de novo \[*PSI*^+^\] and \[*PIN*^+^\] prion formation in autophagy mutants
-------------------------------------------------------------------------------------------------

Strain 74D-694 contains the *ade1-14* mutant allele, which confers adenine auxotrophy due to the presence of a premature UGA stop codon in the *ADE1* gene. Thus \[*psi*^−^\] *ade1-14* cells are unable to grow in the absence of exogenous adenine and accumulate an intermediate in the adenine biosynthetic pathway that causes the colonies to be red. Suppression of the *ade1-14* mutation in \[*PSI*^+^\] cells allows growth in the absence of adenine, giving rise to white or pink colonies. Spontaneous white/pink Ade^+^ colonies were isolated from *atg1*, *atg8*, and *atg19* mutants ([Figure 2A](#F2){ref-type="fig"}). The Ade^+^ phenotype was eliminated by growth in the presence of GdnHCl, giving rise to red Ade^−^ colonies, confirming the de novo formation of \[*PSI*^+^\] in these cells ([Figure 2A](#F2){ref-type="fig"}). Semidenaturing detergent agarose gel electrophoresis (SDD-AGE) was used to provide further evidence that autophagy mutants form \[*PSI*^+^\] prions. \[*PSI*^+^\] prions form SDS-resistant, high--molecular weight aggregates that can be detected using SDD-AGE ([@B35]). Such Sup35 aggregates were detected in a control \[*PSI*^+^\] strain ([Figure 2B](#F2){ref-type="fig"}). Growth of this strain in the presence of GdnHCl shifted Sup35 back to its monomeric size due to the requirement for Hsp104 to propagate \[*PSI*^+^\] prion formation. Similar SDS-resistant, high--molecular weight aggregates were detected in the \[*PSI*^+^\] versions of the *atg1*, *atg4*, *atg8*, and *atg15* mutants, which were also curable by growth in the presence of GdnHCl ([Figure 2B](#F2){ref-type="fig"}).

![The \[*PSI*^+^\] prion is formed in autophagy mutants. (A) \[*PSI*^+^\] prion formation was visualized in the wild-type (74D-694) and *atg1*, *atg8*, and *atg19* mutant strains by pink/white colony formation and growth on minimal medium in the absence of adenine. Curing with GdnHCl gives rise to red Ade^−^ colonies, confirming the de novo formation of \[*PSI*^+^\] in these cells. (B) Cell extracts were prepared from exponentially growing cells and analyzed by SDD-AGE. SDS-resistant Sup35 aggregates were detected in *atg1*, *atg4*, *atg8*, and *atg15* mutant strains. Aggregate and monomer (M) forms are indicated.](4541fig2){#F2}

To quantify \[*PSI*^+^\] formation, we used a plasmid with a *ura3-14* allele containing the *ade1-14* nonsense mutation engineered into the wild-type *URA3* gene ([@B39]). The *ura3-14* allele allows \[*PSI*^+^\] prion formation to be scored by growth on media lacking uracil, indicative of decreased translational termination efficiency in \[*PSI*^+^\] cells. We used this assay rather than scoring \[*PSI*^+^\] formation by suppression of the *ade1-14* nonsense mutation and growth on media lacking adenine to avoid any possible complications arising from adenine metabolism in autophagy mutants. Formation of the red pigment in adenine mutants arises due to its accumulation in vacuoles ([@B9]), and we reasoned that autophagy mutants might affect vacuolar function. \[*PSI*^+^\] formation was differentiated from nuclear gene mutations that give rise to uracil prototrophy by their irreversible elimination in GdnHCl. Using this assay, we estimated the frequency of de novo \[*PSI*^+^\] prion formation in a control \[*PIN*^+^\]\[*psi*^−^\] strain to be ∼1 × 10^−5^ ([Figure 3A](#F3){ref-type="fig"}), comparable to previously reported frequencies ([@B37]; [@B36]). Loss of *ATG1*, *ATG8*, or *ATG19* caused a modest increase in the frequency of de novo \[*PSI*^+^\] formation of approximately twofold to threefold. Given that increased cellular concentration of Sup35 can promote \[*PSI*^+^\] prion formation, we examined Sup35 protein levels in autophagy mutants ([Figure 3B](#F3){ref-type="fig"}). This analysis confirmed that similar levels of Sup5 are present in a wild-type and *atg1*, *atg8*, and *atg19* mutant strains, ruling out any effects on Sup35 protein concentration.

![Increased frequency of de novo \[*PSI*^+^\] and \[*PIN*^+^\] prion formation in autophagy mutants. (A) \[*PSI*^+^\] prion formation was quantified in the wild-type and *atg1*, *atg8*, and *atg19* mutant strains using an engineered *ura3-14* allele, which contains the *ade1-14* nonsense mutation inserted into the wild-type *URA3* gene ([@B39]). \[*PSI*^+^\] prion formation was scored by growth on medium lacking uracil, indicative of decreased translational termination efficiency. \[*PSI*^+^\] formation was differentiated from nuclear gene mutations that give rise to uracil prototrophy by their irreversible elimination in GdnHCl. Data shown are the means of at least three independent biological repeat experiments expressed as the number of colonies per 10^5^ viable cells. Error bars denote the SD. (B) Western blot analysis showing Sup35 protein levels in wild-type and *atg1*, *atg8*, and *atg19* mutant strains. Blots were probed with α-Pgk1 as a loading control. (C) \[*PIN*^+^\] prion formation was quantified in wild-type and *atg1*, *atg8*, and *atg19* mutant strains and is expressed as the number of \[*PIN^+^*\] colonies formed per 96 colonies examined. Data shown are the means of at least three independent biological experiments; error bars denote the SD.](4541fig3){#F3}

Given the increased frequency of \[*PSI*^+^\] prion formation in autophagy mutants, we examined the de novo formation of another yeast prion, namely the Rnq1/\[*PIN*^+^\] prion, which is not related in sequence to the Sup35/\[*PSI*^+^\] prion. The de novo formation of \[*PIN*^+^\] prions was detected in ∼6% of control \[*pin*^−^\] cells ([Figure 3C](#F3){ref-type="fig"}), comparable to previous measurements ([@B51]). The frequency of \[*PIN*^+^\] prion formation was elevated by approximately twofold to threefold in *atg1*, *atg8*, and *atg19* mutants ([Figure 3C](#F3){ref-type="fig"}). Taken together, these data indicate that an increased frequency of de novo prion formation occurs in mutants defective in the core autophagy machinery, suggesting that active autophagy is required to suppress prion formation during normal growth conditions.

The frequency of induced \[*PSI*^+^\] formation is increased in an autophagy mutant
-----------------------------------------------------------------------------------

\[*PSI*^+^\] prion formation can be induced by the overexpression of Sup35 in \[*PIN*^+^\] strains since the excess Sup35 increases the possibility for prion seed formation ([@B61]). Strains were initially grown overnight, before *SUP35NM-GFP* was induced with copper to promote \[*PSI*^+^\] prion formation. We found that overexpression of Sup35NM-GFP in a \[*PIN*^+^\]\[*psi*^−^\] control strain resulted in detectable protein aggregates after 18 h of expression induced by copper addition, and aggregates were detected in ∼4.7% of cells by 24 h ([Figure 4A](#F4){ref-type="fig"}), similar to previous reports ([@B40]). Overexpression of *SUP35NM-GFP* in \[*PIN*^+^\]\[*psi*^−^\] cells facilitates the detection of ring- and ribbon-like aggregates that are believed to be characteristic of de novo prion formation. These structures can be found in the cell periphery or surrounding the vacuole and mature into an infectious prion state, detected as large, dot-like aggregates ([@B21]). Ring and ribbon-like aggregates characteristic of the de novo formation of \[*PSI^+^*\] could be detected in 0.6% of control cells by 18 h ([Figure 4A](#F4){ref-type="fig"}). When the same experiment was repeated in an *atg1* mutant, increased aggregation was detected after overnight growth and induction of *SUP35NM-GFP* for 1 h, as expected from [Figure 1](#F1){ref-type="fig"}. Sup35 aggregation continued to increase in the *atg1* mutant, with 13.6% of cells examined containing visible aggregates after 24 h of *SUP35NM-GFP* expression ([Figure 4A](#F4){ref-type="fig"}). Ring- and ribbon-like aggregates characteristic of the de novo formation of \[*PSI^+^*\] could also be detected within 12 h. Thus autophagy mutants appear to show an increased frequency of both spontaneous and induced \[*PSI^+^*\] prion formation.

![Induction of \[*PSI*^+^\] prion formation in autophagy mutants. (A) Fluorescence micrographs for \[*PIN*^+^\] \[*psi*^−^\] versions of the wild-type and *atg1* mutant strains containing the Sup35NM-GFP plasmid induced with copper for the indicated times. Top rows, representative images in which puncta formation was first detected in the wild-type (18 h) and *atg1* (1 h) strains. Bottom rows, representative images in which rod- and ribbon-like aggregates, indicative of de novo prion formation, were detected in the wild-type (18 h) and *atg1* (12 h) strains. The percentage of cells containing visible puncta or rod- and ribbon-like aggregates is shown for each strain from an average of 300 cells counted. (B) Western blot analysis of the wild-type and *atg1* mutant strains after induction of Sup35NM-GFP for 1, 8, 18, or 24 h. Blots were probed with αSup35 or α-Pgk1 as a loading control. (C) Fluorescence micrographs for cured versions of the wild-type and *atg1* mutant strains after induction of Sup35NM-GFP for 2 or 24 h. Representative images in which puncta were only detected in *atg1* mutant cells (3.6%) after 24-h induction. (D) \[*PSI*^+^\] prion formation was quantified in the wild-type and *atg1* mutant strains containing the *Sup35NM-GFP* plasmid after 0 , 1, and 24 h of copper induction. \[*PSI*^+^\] formation was quantified using the *ade1-14* mutant allele by growth on medium lacking adenine and differentiated from nuclear *SUPX* gene mutations by their irreversible elimination in GdnHC1. Data shown are the means of at least three independent biological repeat experiments expressed as the number of colonies per 10^4^ viable cells. Error bars denote the SD. (E) Sup35 toxicity was examined in \[*psi*^−^\] or \[*PSI*^+^\] versions of the indicated strains containing *SUP35* under the control of a *GAL* inducible promoter. Strains were initially grown overnight in raffinose-containing medium before dilution (*A*~600~ = 1, 0.1, 0.01, 0.001) and spotting onto agar plates containing galactose or glucose. Overexpression of Sup35 inhibits growth in the \[*PSI*^+^\] versions of autophagy mutants compared with \[*psi*^−^\] versions.](4541fig4){#F4}

Sup35 Western blot analysis was used to rule out any differences in *SUP35NM-GFP* induction in the *atg1* mutant compared with the wild-type strain ([Figure 4B](#F4){ref-type="fig"}). This analysis showed that a similar profile of increased *SUP35NM-GFP* was detected in both the wild-type and *atg1* mutant strains. Strains were cured with GdnHCl before *SUP35NM-GFP* overexpression to determine the requirement for Hsp104 for induced puncta formation. No puncta were detected in the cured wild-type strain after 2 or 24 h induction of *SUP35NM-GFP* ([Figure 4C](#F4){ref-type="fig"}). Similarly, no puncta were detected in the *atg1* mutant after 2 h of induction of *SUP35NM-GFP*, but 3.6% of *atg1* mutant cells contained puncta after 24 h of induction ([Figure 4C](#F4){ref-type="fig"}). These data confirm that the induced aggregate formation in the wild type and the *atg1* mutant is largely \[*PIN*^+^\] dependent.

The induction of \[*PSI*^+^\] prion formation was quantified using the *ade1-14* mutant allele, which confers adenine auxotrophy and is differentiated from nuclear *SUPX* gene mutations by its irreversible elimination in guanidine hydrochloride ([@B55]). The frequency of \[*PSI*^+^\] formation was ∼10-fold higher in a wild-type strain containing the Sup35-GFP plasmid before copper induction compared with a nontransformed strain (compare [Figures 4D](#F4){ref-type="fig"} and [3A](#F3){ref-type="fig"}). This presumably reflects increased basal levels of Sup35 expression from the Sup35-GFP plasmid. Before copper induction, the frequency of \[*PSI*^+^\] formation was approximately threefold higher in the *atg1* mutant than with the wild-type strain ([Figure 4D](#F4){ref-type="fig"}). This is very similar to the difference observed between wild-type and *atg1* mutant strains using the *ura3-14* assay ([Figure 3A](#F3){ref-type="fig"}). \[*PSI*^+^\] formation was strongly induced in response to copper addition. This induction was stronger in the *atg1* mutant than with the wild-type strain, confirming that autophagy suppresses induced \[*PSI*^+^\] prion formation ([Figure 4D](#F4){ref-type="fig"}).

Overexpression of Sup35 in a \[*PSI*^+^\] background can be toxic due to increased Sup35 aggregation titrating Sup35 away from its normal function in translation termination ([@B15]; [@B4]; [@B59]). We examined whether autophagy is required to protect against this toxicity. *Sup35* was overexpressed under the control of the *GAL1* promoter in \[*PIN*^+^\]\[*PSI*^+^\] versions of the wild-type and *atg1*, *atg8*, and *atg19* mutant strains. Sup35 overexpression was more toxic in the autophagy mutants than with the wild-type strain ([Figure 4E](#F4){ref-type="fig"}). This toxicity depended on the \[*PSI*^+^\] status of the cells, since it was largely abrogated in \[*PIN*^+^\]\[*psi*^−^\] mutants.

Inducing autophagy protects against de novo \[*PSI*^+^\] prion formation
------------------------------------------------------------------------

Because loss of autophagy results in an increased frequency of prion formation, we examined whether inducing autophagy could protect against de novo *\[PSI^+^\]* prion formation. This is difficult to examine in a wild-type strain, given the rare occurrence of spontaneous \[*PSI*^+^\] prion formation. We therefore used mutants that are known to have an increased frequency of de novo \[*PSI*^+^\] prion formation. This included a mutant lacking the Tsa1 and Tsa2 peroxiredoxins ([@B52]). Peroxiredoxins are important cellular antioxidants, and oxidative damage to Sup35 is believed to trigger the formation of \[*PSI^+^*\] prions in this mutant ([@B51]). A number of factors that modify the frequency of \[*PSI*^+^\] induction were identified in an unbiased genome-wide screen ([@B56]). We used one such mutant identified in this screen that is deleted for *PPQ1* (*SAL6*), encoding a protein phosphatase of unknown function. Ppq1 (Sal6) was originally identified as a mutant that increases the efficiency of translational suppressors, including nonsense suppressors ([@B58]). Rather than affecting prion formation, this mutant presumably allows the detection of \[*PSI^+^*\] strains that are normally too weak to detect. Using the *ura3-14 allele* plasmid assay, we found the frequency of de novo \[*PSI*^+^\] prion formation to be elevated by approximately fourfold in a \[*PIN*^+^\]\[*psi*^−^\] *tsa1 tsa2* mutant and by 20-fold in a \[*PIN*^+^\]\[*psi*^−^\] *ppq1* mutant ([Figure 5A](#F5){ref-type="fig"}). Autophagy can be stimulated by a number of pharmacological agents including the naturally occurring polyamine spermidine ([@B18]; [@B42]). Growth of the *tsa1 tsa2* and *ppq1* mutants in the presence of 4 mM spermidine significantly reduced the elevated frequency of de novo \[*PSI*^+^\] prion formation normally observed in these mutants but not in an *atg1* mutant ([Figure 5A](#F5){ref-type="fig"}).

![Inducing autophagy with spermidine protects against de novo \[*PSI*^+^\] and \[*PIN*^+^\] prion formation. (A) \[*PSI*^+^\] prion formation was quantified in wild-type and *tsa1 tsa2* and *ppq1* mutant strains using an engineered *ura3-14* allele as described for [Figure 3A](#F3){ref-type="fig"}. Autophagy was induced by growing cells in the presence of 4 mM spermidine (+ Spd). (B) Autophagic flux was monitored in cells expressing GFP-Atg8. Growth in the presence of spermidine induced autophagy in wild-type and *tsa1 tsa2* and *ppq1* mutant strains as detected by the appearance of free GFP indicative of autophagic flux. No free GFP was detected in an *atg1* mutant. (C) \[*PIN*^+^\] prion formation was quantified in wild-type and *atg1* mutant cells as described for [Figure 3C](#F3){ref-type="fig"}. Autophagy was induced by growing cells in the presence of 4 mM spermidine (+ Spd).](4541fig5){#F5}

A GFP-Atg8 construct was used as a control to confirm that spermidine induces autophagy in these mutants ([@B43]). This assay follows the autophagy-dependent proteolytic liberation of GFP from GFP-Atg8, which is indicative of autophagic flux. Free GFP was detected in the wild-type and *tsa1 tsa2* and *ppq1* mutant strains after spermidine treatment but not in the *atg1* mutant, which is defective in autophagy ([Figure 5B](#F5){ref-type="fig"}). Of interest, low levels of free GFP were detected in the *tsa1 tsa2* and *ppq1* mutants in the absence of spermidine, suggesting that these mutants already have elevated basal levels of autophagy. Because de novo \[*PIN*^+^\] formation occurs at a relatively high rate, we examined whether inducing autophagy with spermidine also protects against \[*PIN*^+^\] formation. This analysis showed that spermidine reduces de novo \[*PIN*^+^\] formation from ∼6% to \<1% ([Figure 5C](#F5){ref-type="fig"}). Spermidine treatment did not affect the elevated frequency of de novo \[*PIN*^+^\] formation observed in an *atg1* mutant.

Sup35 protein oxidation is increased in autophagy mutants
---------------------------------------------------------

To begin to address the mechanism by which prions form spontaneously in autophagy mutants, we examined whether the localization of \[*PSI*^+^\] foci is altered in an autophagy mutant. Induced \[*PSI*^+^\] prion formation is believed to proceed via targeted localization of misfolded Sup35 to the IPOD, which is formed adjacent to the vacuole ([@B57]; [@B53]). The vacuolar dye FM4-64 was used to visualize vacuolar membranes in wild-type and *atg1* mutant strains ([Figure 6A](#F6){ref-type="fig"}). This analysis revealed that similar vacuolar Sup35-GFP foci were detected in the wild-type and *atg1* mutant strains after copper induction of the *SUP35NM-GFP* fusion ([Figure 6A](#F6){ref-type="fig"}). We used CFP-ATG8 and CFP-ATG14 as markers of the preautophagosomal structure (PAS) in wild-type and *atg1* mutant strains ([Figure 6B](#F6){ref-type="fig"}). Similar to previous reports ([@B57]), we observed that Sup35-GFP foci formed adjacent to these PAS markers. Similar Sup35-GFP foci were formed in the *atg1* mutant despite the absence of PAS formation. Thus, although an *atg1* mutant is deficient in macroautophagy and the recruitment of additional Atg proteins to the PAS ([@B45]), Sup35 is still targeted to the vacuolar membrane.

![Sup35 aggregate formation occurs at similar intracellular sites in wild-type and *atg1* mutant strains. (A) The vacuolar dye FM4-64 was used to visualize vacuolar membranes in wild-type and *atg1* mutant strains. Similar vacuolar Sup35-GFP foci were detected in the wild-type and *atg1* mutant strains after copper induction of the *SUP35NM-GFP* fusion construct for 1 h. (B) CFP-ATG8 and CFP-ATG14 were used as markers of PAS in wild-type and *atg1* mutant strains. Strains were grown for 48 h in the presence of 4 mM spermidine to induce autophagy and *SUP35NM-GFP* induced with copper for 1 h. Sup35 aggregates form adjacent to PAS markers in the wild-type strain.](4541fig6){#F6}

Given that vacuolar targeting of Sup35 appears to be unaffected in an *atg1* mutant, we next examined whether oxidatively damaged Sup35 accumulates in an autophagy mutant, which might trigger \[*PSI*^+^\] prion formation. This is because oxidative damage to Sup35 is believed to be one possible cause of the initial misfolding event that triggers the formation of the \[*PSI*^+^\] prion in yeast ([@B51]). We previously showed that loss of antioxidants results in elevated levels of Sup35 methionine oxidation and \[*PSI*^+^\] prion formation, suggesting that endogenous levels of reactive oxygen species (ROS) are sufficient to promote prion formation ([@B51]). We reasoned that if autophagy acts to suppress prion formation by removing oxidatively damaged Sup35, we might detect oxidized Sup35 in an autophagy mutant. Sup35 oxidation was measured by immunoblot analysis using an antibody that recognizes methionine sulfoxide (MetO). No MetO was detected in a wild-type strain grown under nonstress conditions, but MetO was detected after exposure to 1 mM hydrogen peroxide for 1 h ([Figure 7A](#F7){ref-type="fig"}). Formation of MetO was also detected in the *tsa1 tsa2* mutant, as previously reported ([@B51]). In addition, MetO formation was detected in an *atg1* mutant in the absence of oxidative stress, suggesting that autophagy normally functions to remove oxidatively damaged Sup35 that forms during normal growth conditions and endogenous ROS exposure.

![Oxidation of Sup35 in an *atg1* mutant causes \[*PSI*^+^\] prion formation. (A) Sup35 was affinity purified using TAP chromatography from wild-type and *atg1* and *tsa1 tsa2* mutant strains. Western blots were probed with anti-PAP (peroxidase anti-peroxidase) to confirm that similar amounts of Sup35 were purified from each strain. Sup35 oxidation was detected using antibodies that recognize MetO. Strains were treated with 1 mM hydrogen peroxide where indicated. (B) Sup35 methionine oxidation was detected in wild-type and *atg1* mutant strains grown under aerobic vs. anaerobic conditions. Western blots were probed with anti-Sup35 to confirm that similar amounts of Sup35 were purified from each strain. (C) \[*PSI*^+^\] prion formation was quantified in wild-type and *atg1* mutant strains after growth under aerobic or anaerobic conditions.](4541fig7){#F7}

Given that oxidatively damaged Sup35 accumulates in an *atg1* mutant, we examined whether oxidative damage underlies the increased frequency of \[*PSI*^+^\] prion formation in an autophagy mutant. The \[*PIN*^+^\]\[*psi*^−^\] versions of the wild-type and *atg1* mutant strains were grown under aerobic or anaerobic conditions in the absence of molecular oxygen. Examination of Sup35 methionine oxidation revealed that no MetO was detected in the *atg1* mutant after growth under anaerobic conditions ([Figure 7B](#F7){ref-type="fig"}). Under aerobic conditions, the frequency of \[*PSI*^+^\] prion formation was elevated by approximately threefold, whereas no increased \[*PSI*^+^\] prion formation was detected in the *atg1* mutant grown under anaerobic conditions ([Figure 7C](#F7){ref-type="fig"}). These data indicate that oxidative growth conditions are required for the increased frequency of prion formation in an autophagy mutant.

DISCUSSION
==========

Prions form spontaneously without any underlying genetic change. The emergence of disease correlates with the appearance of PrP^Sc^, a novel conformational form of the cellular PrP protein. This prion form replicates through a cycle of seeded polymerization and fragmentation, and it is assumed that genetic or environmental factors can trigger the conformational change in the absence of any preexisting PrPSc "seeds" ([@B11]). However, the exact mechanisms underlying the switch from a normally soluble protein to the amyloid form are poorly understood. Prions cause many neurodegenerative diseases, including Alzheimer's, Parkinson's, and Creutzfeldt--Jakob diseases and amyotrophic lateral sclerosis. Most cases of these human diseases are sporadic ([@B48]). It is therefore important to establish the conditions that trigger the switch to the prion or disease-causing form. Our data indicate that autophagy is required to suppress de novo formation of the yeast \[*PSI*^+^\] and \[*PIN*^+^\] prions.

Mutants lacking several different core and associated autophagy components were found to elevate prion formation. In contrast, mutants lacking *ATG11* or *ATG32*, which are deficient in pexophagy and mitophagy, respectively, were unaffected in aggregate formation. Mutants lacking *ATG19* also displayed increased spontaneous aggregate formation. This was somewhat unexpected because Atg19 is believed to function as an essential component of the cytoplasm-to-vacuole targeting pathway (Cvt) rather than in nonselective autophagy ([@B63]). However, there is some evidence for a role for Atg19 in the degradation of an ER-associated degradation substrate ([@B41]). Atg19 is required for the efficient degradation of Pma1 in a process that also requires the UPS. It is unclear whether Sup35 may act as a substrate of the Cvt pathway or whether Sup35 aggregation and \[*PSI*^+^\] prion formation are indirect effects of loss of Atg19. This does not appear to arise specifically due to loss of the Cvt pathway, since Sup35 aggregation and \[*PSI*^+^\] prion formation are unaffected in a mutant lacking Atg11, which functions as an adapter protein required for cargo loading in pexophagy and the Cvt pathway.

The frequency of de novo \[*PSI*^+^\] formation is relatively low in a wild-type strain (∼1 × 10^−5^) and is elevated by approximately twofold to threefold in mutants lacking *ATG1*, *ATG8*, or *ATG19.* In contrast, Sup35NM-GFP aggregate formation was detected in ∼4--5% of cells examined for the same autophagy mutants. This suggests that not all cells with fluorescent aggregates correspond to true \[*PSI*^+^\] formation. It has long been known that not all SUP35-GFP aggregates will give rise to prions. For example, previous studies suggested that about half of cells with fluorescent dots will die. Some of the rest contain nonproductive (e.g., nonamyloid) aggregates ([@B5]). Thus, whereas overexpressing SUP35-GFP provides a way to look for the general propensity to promote aggregate formation, it does not distinguish among aggregates that will be dissolved/cleared by autophagy, the ones that will kill the cell, and the ones that will give rise to \[*PSI*^+^\]. Our quantitative assay specifically quantifies "classical" PIN-dependent \[*PSI*^+^\] formation, that is, prions that are capable of propagation and strong enough to give rise to viable colonies. \[*PSI*^+^\] formation is strongly induced in response to copper addition, as expected. This induction is stronger in the *atg1* mutant than in the wild-type strain, confirming that autophagy suppresses induced \[*PSI*^+^\] prion formation. Furthermore, taking the wild-type strain as an example, these experiments confirm that the frequency of true \[*PSI*^+^\] formation (1.2 × 10^−4^) is much lower than the number of cells containing visible Sup35-GFP aggregates (4.7 × 10^−2^).

Sup35 containing oxidized methionine (MetO) was detected in the *atg1* mutant, which appears to underlie the increased frequency of \[*PSI*^+^\] prion formation in this mutant. Increasing evidence suggests a causal link between protein oxidation and de novo prion formation ([@B23]). For example, oxidized methionine residues detected in misfolded PrP^Sc^ have been proposed to facilitate the structural conversion underlying the sporadic formation of PrP^Sc^ ([@B12]; [@B62]; [@B19]). Similarly, we showed that methionine oxidation of Sup35 in a range of yeast antioxidant mutants underlies the switch from a soluble form of the protein to the \[*PSI*^+^\] prion ([@B51]; [@B17]). Abrogating methionine oxidation in antioxidant mutants prevents \[*PSI*^+^\] formation, suggesting that protein oxidation may be a common mechanism underlying the aggregation of both mammalian and yeast amyloidogenic proteins ([@B51]; [@B17]). Similar increases in the levels of Met-SO formation were detected in *tsa1 tsa2* and *atg1* mutant strains and in a wild-type strain exposed to hydrogen peroxide. Note that the immunoblots used to detect Met-SO levels do not provide a quantitative measure of methionine oxidation, but the detection of oxidized methionine has been shown to correlate with elevated frequencies of \[*PSI*^+^\] formation ([@B17]). We do not know why MetO formation appears to decrease in *atg1* mutant cells after oxidative stress conditions. It is possible that the excess accumulation of oxidized proteins that might arise from the combination of oxidative stress and the loss of *atg1* is toxic to cells, or, alternatively, other protein degradation or aggregate-clearing systems may become active under these conditions. We suggest that autophagy normally functions to remove oxidized Sup35 from cells, but in the absence of autophagy, misfolded Sup35 undergoes structural transitions favoring its conversion to the propagatable \[*PSI*^+^\] form. In agreement with this idea, growth under anaerobic conditions abrogated both methionine oxidation and the increased frequency of \[*PSI*^+^\] formation in an *atg1* mutant.

Met-SO was detected in Sup35 in an *atg1* mutant grown under normal conditions in the absence of any added oxidant. This suggests that endogenous ROS levels are sufficient to damage Sup35 but that autophagy normally functions to remove damaged Sup35, preventing \[*PSI*^+^\] formation. The frequency of prion formation was lower in the *atg1* mutant than in antioxidant mutants under the same growth conditions. This presumably reflects the higher levels of endogenous ROS that are formed in the absence of antioxidants. A significant proportion of newly synthesized proteins are known to be misfolded, and this is exacerbated by conditions that promote further unfolding, such as oxidative stress ([@B27]). These oxidized proteins are often nonfunctional and must be removed by degradation to prevent aggregate formation. The UPS and auto­phagy are the major routes of clearance for toxic proteins. The UPS is believed to mainly degrade short-lived proteins, whereas autophagy degrades high--molecular weight protein aggregates commonly seen in neurodegenerative disorders. Not surprisingly, therefore, dysregulation of autophagy has been implicated in the pathogenesis of neurodegenerative disorders, since aggregate-prone are eliminated more efficiently via the autophagy pathway than the UPS ([@B6]; [@B38]). Sup35 has been shown to be a proteasomal substrate, and proteasomal activity has been demonstrated to influence \[*PSI*^+^\] propagation ([@B33]). The proteasome was found to degrade highly ordered prion protein assemblies in a manner that does not require ubiquitination. It therefore seems likely that the UPS and autophagy provide overlapping defense systems to protect against prion formation and propagation.

It is difficult to model sporadic prion formation without overexpressing the corresponding protein. We used mutants that display an elevated frequency of \[*PSI*^+^\] prion formation without any underlying effect on Sup35 protein levels to test whether increasing autophagic flux could protect against prion formation. The elevated frequency of \[*PSI*^+^\] prion formation was abrogated in a *tsa1 tsa2* mutant after induction of autophagy using spermidine. This does not simply reflect the role of autophagy in the turnover of oxidized proteins, since \[*PSI*^+^\] prion formation was also reduced in a *ppq1* mutant that is not involved in the oxidative stress response. The nature of the misfolded intermediate in a *ppq1* mutant is unknown but is presumably normally removed via autophagy to prevent prion formation. Enhancing autophagy has also been shown to reduce toxicity in Huntington's disease models ([@B50]), suggesting that pharmacological agents that increase autophagic flux may represent a promising therapeutic route toward protecting against amyloid formation and toxicity

The role of autophagy in preventing prion formation and toxicity appears evolutionarily conserved. Previous studies established the importance of autophagy for delivery of PrP^Sc^ to lysosomes for degradation in chronically infected cells ([@B26]; [@B22]). Similarly, inhibitors of autophagy result in increased levels of PrP^Sc^, and stimulating autophagy decreases PrP^Sc^ levels ([@B1]; [@B25]; [@B22]; [@B28]; [@B30]). Autophagy also appears to be stimulated in response to the de novo accumulation of prion aggregates, which may act to clear PrP^Sc^. For example, PrP accumulates as ubiquitinated intracellular protein inclusions, which causes induction of endoplasmic reticulum chaperones, the unfolded protein response, and autophagy in a mouse model of prion disease ([@B30]). It is interesting, therefore, that the basal levels of autophagy were also somewhat elevated in the *ppq1* and *tsa1 tsa2* mutants, which show an elevated frequency of \[*PSI*^+^\] prion formation. Yeast therefore provides a powerful genetic system to further establish and identify the protective systems that protect against the spontaneous formation of prions.

MATERIALS AND METHODS
=====================

Yeast strains and plasmids
--------------------------

The wild-type yeast strain 74D-694 (*MATa ade1-14 ura3-52 leu2-3112 trp1-289 his3-200*) was used for all experiments. Strains deleted for autophagy genes were constructed in 74D-694 using standard yeast methodology. Sup35 was tagged at its C-terminus with a tandem affinity purification (TAP) tag and was described previously ([@B51]). Sup35 was overexpressed using an inducible *GAL1-Sup35* plasmid ([@B31]). Plasmids expressing CFP-ATG8 and CFP-ATG14 were described previously ([@B57])

Growth and stress conditions
----------------------------

Strains were grown at 30°C with shaking at 180 rpm in rich YEPD medium (2% \[wt/vol\] glucose, 2% \[wt/vol\] bactopeptone, 1% \[wt/vol\] yeast extract) or minimal SD (0.67% \[wt/vol\] yeast nitrogen base without amino acids, 2% \[wt/vol\] glucose) supplemented with appropriate amino acids and bases. SGal media contained 2% (wt/vol) galactose, and SRaf media contained 2% (wt/vol) raffinose in place of glucose. Media were solidified by the addition of 2% (wt/vol) agar. Strains were cured by five rounds of growth on YEPD agar plates containing 4 mM GdnHCl. Anaerobic growth conditions were established by degassing media with nitrogen gas as previously described ([@B7]).

Analyses of prion formation
---------------------------

A plasmid containing an engineered *ura3-14* allele, which contains the *ade1-14* nonsense mutation in the wild-type *URA3* gene ([@B39]), was used to score the frequency of de novo \[*PSI*^+^\] prion formation as previously described. Alternatively, \[*PSI*^+^\] prion formation was scored by growth in absence of adenine. De novo \[*PIN^+^*\] formation was performed as previously described ([@B51]). \[*PSI*^+^\] and \[*PIN^+^*\] formation was calculated based on the mean of at least three independent biological repeat experiments. De novo \[*PSI*^+^\] prion formation was visualized as described previously using *CUP1-SUP35NM-GFP* ([@B51]). The number of cells containing Sup35 puncta was quantified from ∼300 cells counted.

Protein analysis
----------------

The analysis of Sup35 amyloid polymers by SDD-AGE was performed as described previously ([@B3]). Sup35-TAP affinity purification and detection of methionine oxidation were performed as described previously ([@B51]).

Autophagy analysis and induction
--------------------------------

Autophagy was induced by growth in the presence of 4 mM spermidine ([@B18]). The induction of autophagy was confirmed by examining the release of free GFP due to the proteolytic cleavage of GFP-Atg8 using a plasmid described previously ([@B43]).
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